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ABSTRACT
BIAS CORRECTION IN FINDING COPY NUMBER
VARIATION WITH USING READ DEPTH-BASED
METHODS IN EXOME SEQUENCING DATA
Fatma Balcı
M.S. in Computer Engineering
Supervisor: Assist. Prof. Can Alkan
August, 2014
Medical research has striven for identifying the causes of disorders with the
ultimate goal of establishing therapeutic treatments and finding cures since its
early years. This aim is now becoming a reality thanks to recent developments in
whole genome (WGS) and whole exome sequencing (WES). Despite the decrease
in the cost of sequencing, WGS is still a very costly approach because of the
need to evaluate large number of populations for more concise results. Therefore,
sequencing only the protein coding regions (WES) is a more cost effective alterna-
tive. With the help of WES approach, most of the functionally important variants
can be detected. Additionally, single nucleotide polymorphisms (SNPs) that are
located within coding regions are the most common causes for Mendelian diseases
(i.e. diseases caused by a single mutation). Moreover, WES approaches require
less analysis effort compared to whole genome sequencing approaches since only
1% of whole genome is sequenced. Besides the advantages, there are also some
shortcomings that need to be addressed such as biases in GC−content and probe
efficiency. Although there are some previous studies on correcting GC−content
related issues, there are no studies on correcting probe efficiency effect. In this
thesis, we provide a formal study on the effects of both GC−content and probe
efficiency on the distribution of read depth in exome sequencing data. The cor-
rection of probe efficiency will make it possible to develop new CNV discovery
methods using exome sequencing data.
Keywords: Copy number variations, read depth, bias correction, GC content,
exome sequencing, next-generation sequencing, probe efficiency, DNA sequencing.
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O¨ZET
DI˙ZI˙ DERI˙NLI˙G˘I˙ YO¨NTEMI˙ KULLANILARAK KOPYA
SAYISI FARKLILIKLARINI TESPI˙T ETMEDE EKZOM
DI˙ZI˙LEME DATALARINDA VAROLAN ETKI˙LERI˙N
DU¨ZELTI˙LMESI˙
Fatma Balcı
Bilgisayar Mu¨hendislig˘i, Yu¨ksek Lisans
Tez Yo¨neticisi: Yrd. Doc¸. Can Alkan
Ag˘ustos, 2014
I˙nsanlıg˘ın varolus¸undan bu yana tıptaki aras¸tırmalar, hastaları tedavi ede-
bilmek ve hastalıkların c¸aresini bulabilmek adına bunların altında yatan sebep-
leri bulmak ic¸in yapılmıs¸tır. Bu amac¸, son zamanlarda tu¨m genom ve tu¨m ek-
zom dizilemede yas¸anan gelis¸meler sayesinde gerc¸ekles¸tirilebilmektedir. Dizileme
maliyetlerinde yas¸anan azalmalara rag˘men, daha dog˘ru sonuc¸lar elde edebilmek
adına c¸ok sayıda insan genomunun dizilenme ihtiyacı oldug˘undan tu¨m genom
dizileme halen yu¨ksek maliyetli bir yo¨ntemdir. Bu sebeple, sadece protein kod-
layan bo¨lgeleri dizileyen tu¨m ekzom dizileme yo¨ntemi nispeten daha az maliyetli
bir alternatiftir. Tu¨m ekzom dizileme yaklas¸ımlarının yardımıyla, fonksiyonel
o¨nem tas¸ıyan varyantların c¸og˘u bulunabilmektedir. Buna ek olarak, Mendeliyen
(tek mutasyon kaynaklı) hastalıkların en bu¨yu¨k sebebi olan tek nu¨kleotid polimor-
fizmlerinden, ekzon bo¨lgelerinde yer alanlar da bulunabilmektedir. Ayrıca tu¨m
ekzom dizilemeye dayalı yaklas¸ımlar, insan genomun sadece %1´lik kısmını kap-
sadıg˘ından dig˘er yaklas¸ıma go¨re analiz yaparken daha az c¸aba gerektirmektedir.
Ancak dog˘ru sonuc¸lar elde edebilmek ic¸in ekzom dizileme datasında varolan prob
etkinlig˘i ve GC ic¸erig˘i gibi sapma etkilerinin duzeltilmesi gerekmektedir. Bun-
lardan GC ic¸erig˘i sapmasını du¨zeltmek icin yapılmıs¸ bazı c¸alıs¸malar bulunmak-
tadır. Ancak literatu¨rde, prob etkinlig˘i sapmasını du¨zeltmek amacıyla yapılan bir
c¸alıs¸ma bulunmamaktadır. Bu tezde ekzom dizileme datasına ait dizi derinlemesi
dag˘ılımında varolan prob etkinlilig˘i ve GC ic¸erig˘i sapmaları u¨zerinde c¸alıs¸ılmıs¸tır.
Prob etkinlig˘i sapmasının du¨zeltilmesiyle birlikte, ekzom dizileme datası kullanan
yeni kopya sayısı varyantı bulma metotları gelis¸tirilmek mu¨mku¨n olacaktır.
Anahtar so¨zcu¨kler : Kopya sayısı farklılıkları, dizi derinlig˘i, etki du¨zeltme, GC
ic¸erig˘i, ekzom dizileme, yeni nesil dizileme, prob verimlilig˘i, DNA dizileme.
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Chapter 1
Introduction
Although giant strides have been made in recent years in the field of bioinfor-
matics, there remains an open question as to find copy number variation (CNV)
more accurately to better understand the underlying genetic causes of several
diseases, such as autism and schizophrenia. There are four basic sequence signa-
tures that can be used to identify CNV (see Section 3.2); but the read depth-based
method is the most reliable with whole exome sequencing (WES) data. However,
there are several errors in coverage, named biases, introduced in exome capture,
which prevent this method to work accurately, as they dramatically alter the
read depth distribution properties, and they fail to provide accurate results data
because of these biases.
GC-content and probe capture efficiency are two causes of the biases in exome
sequencing data. Some studies exist in the literature to correct the GC-content
bias, although most have limitations. Moreover, there isn’t any work about probe
capture efficiency. This thesis characterizes the effects of GC-content affecting
exome sequencing read depth distribution; and demonstrates that the correc-
tion of GC-content and probe capture efficiency simultaneously works better in
smoothing the depth distribution. Our study described in the following chapters
attempts to decrease the biases in WES data through identifying the effects of
both GC-content and probe capture efficiency in the read depth distribution for
accurately characterizing CNV. We also provide an insight into how to correct
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for these biases using a well-known statistical smoothing technique, called locally
weighted scatterplot smoothing (LOESS). After this error correction step, it will
be easier to apply more standard CNV identification algorithms to better discover
CNV using WES data.
In chapter 2, we present background information to help better understand
the biological and technical concepts. We define the biases, and provide compar-
isons of CNV discovery algorithms, and provide the basic steps of these methods
in Chapter 3. In Chapter 4, we discuss the related previous studies. The descrip-
tion of the experiment is given in detail in Chapter 5. Finally, we evaluate our
formulations and source of bias characterizations in Chapter 6.
1.1 Motivation
Obtaining accurate knowledge of nucleic acid composition is crucial to all life
sciences. Deciphering DNA sequences started to shed light on novel biological
functions and phenotypic differences, which increased the demand for highly ef-
ficient sequencing technologies. As a consequence, an era of synthetic genomics
and personalized medicine is expected to start within the next few years.
The aim of this thesis is to help to find copy number variation (CNV) accu-
rately in whole exome sequencing (WES) data by calculating read depth (RD)
to be able to get rid of the analysis burden of whole genome sequencing (WGS)
data.
The new cost-efficient and high throughput strategies for DNA sequencing
are now the leading power house of discoveries in life sciences. The new sequenc-
ing technologies, commonly referred to as high throughput sequencing (HTS), or
next-generation sequencing (NGS) started to appear in 2007. The advantages of
HTS platforms are many: Cost of sequencing is reduced 10,000-fold, while data
throughput is increased 30-fold per base per day. Despite the improvements, data
generated with HTS platforms are more difficult to analyze without a priori in-
formation, however the availability of whole genome assemblies for humans and
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all major model organisms has strengthened the potential utility of HTS.
In addition, general progress in technology across other related fields, includ-
ing chemistry, nucleotide biochemistry, computation, data storage, and others,
helped make better use of the HTS data. However, we still need to improve
algorithms to better characterize genomic variation. Although the methods to
discover and genotype single nucleotide polymorphisms (SNPs) are maturing, ac-
curate detection of copy number variation (CNV) is still lacking, but there exist
some algorithms with different strengths and weaknesses in the literature. [2]
1.2 Problem Statement
Depth of coverage is the average number of reads representing a given nu-
cleotide in the reconstructed sequence. Most of the CNV discovery methods using
WGS data perform statistical tests based on a Poisson model, in which reads are
assumed to be distributed uniformly across the genome, since the sequence reads
are assumed to be chosen randomly from the genome. It means RD in a region
should follow a Poisson distribution with mean directly proportional to the size
of the region and to the copy number. However, this assumption hardly holds
even for normal genomes due to the biases mentioned in Chapter 3.
GC-content and probe capture efficiency are two sources of bias in data. GC-
content is the percentage of guanine (G) and cytosine (C) bases in a genomic
region. GC-abundance is heterogeneous across the genome and often correlated
with functionality so it affects each region differently and needs to be corrected.
Exome sequencing involves exon-capture step by which the coding regions are
selected from the total genome DNA by means of hybridization. The characteris-
tics of the probe, such as length, conformation and abundance on the solid phase,
are of relevance in determining the capture efficiency. This capture efficiency is
different for each probe due to the characteristics. Probe capture efficiency de-
termines whether if an exon will be captured or not and the length of the region
captured. Therefore, it also needs to be corrected.
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CNV discovery methods with using WES data is mostly affected by GC-
content and probe capture efficiency biases that can only be corrected locally
with using smoothing methods to be able to reveal data points including CNV in
the graph.
Although there are lots of computational methods and tools in the field to
find CNV by using read depth-based (RD-based) methods, all of them suffer from
various types of biases. After the work completed in this thesis, almost all of the
tools will work more reliably by enhancing data.
1.3 Contributions
Learning more about the relationship between copy number variation (CNV)
and exome sequencing, could help understanding the effects of CNV on humans
and lead to huge improvements on comprehending of the underlying causes of
some important diseases and phenotypic changes of humans. Although CNV
can affect the other species, we are only interested in human genomes, since
most available whole exome sequencing (WES) data are generated from human
samples. There is a problem in finding the underlying causes of some important
diseases such as schizophrenia and cancer.
Despite the great number of researches on finding CNV, most of them is
based on finding CNV in whole genome sequencing (WGS) data. This problem
has negatively impacted by the magnitude of the WGS data because a human
genome is approximately comprised of 3 billion nucleotides. There are some
powerful tools available to find CNV in WGS data. It seems like that they
can be used for whole exome sequencing (WES) data, but the usage of these
tools is not possible due to some biases. A possible cause of this problem is the
difference between probe efficiencies. A study which investigates to understand
the relationship between probes and read depth by improving an algorithm could
remedy to use WES data with some healing.
Firstly, we need to find the read depth and GC-content of the exon regions
4
in the samples’ genomes. We benefit from the 1000 Genomes data and Agilent
Sure Select Capture Kit data with this aim. After reducing some noises in data,
such as sex chromosomes, we calculate the correlation coefficient to understand
the relationship between read depth and probe efficiency. We demonstrated that
there is an important relationship between read depth and probe efficiency.
At the end of this process, we should normalize the data with the help of locally
weighted scatterplot smoothing (LOESS) method because each bases in WES data
are generally affected by the regions that are close to them. Therefore, we need to
evaluate each DNA regions locally. We need to correct data as much as possible
to be able to develop statistical approaches with using WES data. The hardest
part of this process is to separate bias-based and CNV-based deviations in the
data.
People who are working in the field of bioinformatics, patients with genetic
diseases, doctors who want to understand the underlying causes of genetic dis-
eases, and scientists who work in the related fields of science may benefit from
this thesis. If successful tools we plan to develop using the methods presented in
this thesis may also be used in clinical sequencing tests that we expected to be
used in all hospitals within the next few years.
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Chapter 2
Background
2.1 DNA Sequencing
2.1.1 DNA
The hereditary material in humans and almost all other organisms is called as
deoxyribonucleic acid (DNA). Human DNA is mostly found in the cell nucleus,
but it can also be found in the mitochondria in a small amount. Adenine (A),
cytosine (C), guanine (G), and thymine (T) are the coding elements of DNA,
nucleotides.
Adenine and thymine are called as purines, whereas cytosine and guanine
are called as pyrimidines. Each nucleotide consists of a phosphate group, a 5-
carbon sugar (deoxyribose), and a nitrogen containing base attached to the sugar.
These four types of nucleotides differ only in the nitrogenous base. The order of
these nucleotides determines the information to build and maintain an organism.
Nucleotides are located in two long strands that form a spiral, double helix.
Almost each cells in our body has the same DNA. Approximately, 3 billion bases
exist in human DNA.
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Figure 2.1: The grey ribbons that represent the sugar-phosphate backbone have
arrows that run in opposite directions to indicate that the two strands of the
helix are arranged in an anti-parallel manner. The upper end of one strand is
labeled five prime (5’), and the lower end of the same strand is labeled three
prime (3’). The nucleotide bases are shown as differently colored rectangles. The
nucleotide guanine (G), shown in blue, binds with the nucleotide cytosine (C),
shown in orange and the nucleotide adenine (A), shown in green, binds with the
nucleotide thymine (T), shown in red. Gold spheres represent phosphorus atoms,
grey spheres represent carbon atoms, white spheres represent hydrogen atoms,
red spheres represent oxygen atoms, and blue spheres represent nitrogen atoms.
This figure is adapted from [3].
2.1.2 Gene
The principle physical and functional unit of heredity is called as a gene. A
gene is used as a template to make protein molecules and they are made up from
DNA. The number of genes found in a human body has been estimated between
20.000 and 25,000 by the Human Genome Project. There are two copies of genes
in human genomes. One of them is inherited from mother, whereas another is
from father. Almost all genes are common between humans except 1% of the
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genes.
2.1.3 Chromosome
The thread-like structures in which DNA located in human body are called
as chromosomes. 46 chromosomes are found in each human cell. 23 of them
are inherited from mother, whereas the remaining 23 of them are inherited from
father. Humans have 22 pairs of autosomes and one pair of sex chromosomes, the
X and Y.
Autosomes are roughly ordered due to their size. The largest chromosome
is Chromosome 1 which has approximately 2,800 genes. Moreover, the smallest
chromosome is Chromosome 22 which has approximately 750 genes. These genes
are providing instructions for making proteins. Changes in the structure or num-
ber of copies of a chromosome can cause problems with health and development,
but it doesn’t have to cause any problems.
Figure 2.2: Human chromosomes. This figure is adapted from [4].
A pair of sex chromosomes are found in each human normally. Females have
two X chromosomes, whereas male have one X and one Y chromosome.
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2.2 DNA Sequencing Technologies
Nucleic acid sequencing is a way to determine the exact order of the DNA. The
usage of nucleic acid sequencing has become accessible for researchers in the past
decade. These sequencing techniques are key tools in many fields ranging from
archeology, genetics, anthropology, biotechnology, forensic sciences to molecular
biology. As the first major foray into DNA sequencing, The Human Genome
Project is completed in 2004 at the cost of approximately $3 billion. It was a
14-year-long endeavor. The project is completed with using Sanger sequencing
which is developed in 1975 by Frederick Sanger.
There are different kinds of platforms for DNA sequencing in the market. Four
generations of DNA sequencing technologies can be distinguished by their nature
and the kind of output they provide. The field of DNA sequencing technology
development has a rich and diverse history.
2.2.1 Sanger Sequencing (First-Generation Sequencing
Technology)
Sanger sequencing method had become the gold standard for 30 years after
its discovery in 1977. This method uses DNA polymerase which makes use of
inhibitors that terminate the newly synthesized chains at specific residues.
DNA to be sequenced can be prepared in two different ways, shotgun de novo
sequencing or targeted resequencing. The output of both methods is an amplified
template. Then, template denaturation, primer annealing, and primer extension
are performed in a cycle sequencing. Primer is an oligonucleotide complementary
to target DNA and leads the DNA extension. With the help of fluorescently
labeled ddNTPS, each round of primer extension is halted. Labeled ddNTPs
in its current form are mixed with regular, non-labeled, and non-terminating
nucleotides in a cycle sequencing reaction. The label on the terminating ddNTP
of any fragment corresponds to the nucleotide identifying its terminal position.
To separate sequences by length and to provide subsequent interrogation of the
9
terminating base capillary electrophoresis is applied. Software provides DNA
sequences and also their error probabilities for each base-call. [5] [6]
Figure 2.3: Workflow of the Sanger Sequencing Method. This figure is adapted
from [7].
2.2.2 Next-Generation Sequencing (Second-Generation
Sequencing Technology)
Machine Capacity Speed Read Length Cost Per Base
454 Roche 35-700 Mb 10-23 hours 400-700 bp 714/14285× 10−8 e
SOLiD 90-180 Gb 7-12 days 75 bp 3/5× 10−8 e
Illumina 6-600 Gb 2-14 days 100-250 bp 2/333× 10−8 e
Ion Torrent 20 Mb-1 Gb 4-5 hours 200 bp 100/10000× 10−8 e
PacBio 1 Gb 30 minutes 3,000 bp 60/80× 10−8 e
Table 2.1: Comparison of the DNA sequencers. This table is adapted from [8].
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After the completion of the Human Genome Project, cheaper and faster sequenc-
ing methods are demanded in the market. This demand has revealed the devel-
opment of next-generation sequencing (NGS) methods. NGS is used for a fast,
affordable, and through way to determine the underlying genetic causes of dis-
eases. Millions of fragments of DNA from a single sample can be sequenced in
unison with NGS. Massively parallel sequencing technology performed in NGS
facilitates high-throughput sequencing. With this technology an entire genome
are sequenced in less than ten days. In addition to these advantages of NGS, the
cost required for a whole human genome has decreased with this technology. It is
also minimizing the need for the fragment-cloning methods which are frequently
used in Sanger sequencing.
Figure 2.4: Workflow of the next-generation sequencing. This figure is adapted
from [8].
After the appearance of the first 2nd generation sequencer in 2005, several
second generation sequencers followed this emergence in the market. They are
working conceptually similar although they have differences in sequencing bio-
chemistry as well as in how the array is sequenced.
2.2.2.1 454/Roche
The first next-generation sequencing technology was 454 pyrosequencing.
454/Roche sequencing method consists of library preparation, emulsion PCR,
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and pyrosequencing.
454 is based on the ”sequencing by synthesis principle” which means taking
the single stranded DNA to be sequenced and sequencing its complementary in
an enzymatic way. In this method the activity of DNA polymerase is monitored
by another enzyme, chemiluminescene. When the complementary is bound by
the single-stranded sequenced DNA, light is produced. Sequencing is completed
by the produced chemiluminescent signals [6].
Figure 2.5: 454/Roche Machines. This figure is adapted from [8].
2.2.2.2 ABI Solid
Emulsion PCR is used to generate the clonal sequencing features in the se-
quencing process of ABI Solid sequencing technology. Di-base sequencing tech-
nique in which two nucleotides are read via sequencing by ligation is used at each
step of the sequencing process.
Although there are 16 base combinations of di-bases are possible, 4 dyes are
used by the system. Therefore, 4 di-bases are represented by a single color. All
bases are interrogated twice by the sequencing machine. Each following base can
be derived in this way if the previous base is known. Moreover, a misidentified
color can change all of the following bases in the translation. ABI Solid is rarely
preferred nowadays. [9]
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Figure 2.6: ABI Solid Machine and its procedure. This figure is adapted from
[8].
2.2.2.3 Illumina
Although better platforms exist in the market, Illumina is the market leader
due to the lower prices. Data produced by Illumina’s machine is also used in this
project. Illumina sequencing is comprised of library preparation, clustering, and
sequencing processes.
In the first part, DNA simultaneously fragment and tag the extracted and
purified DNA with adapters. Reduced cycle amplification adds the sequencing
primary binding sites, indices, and regions that are complementary to the flow
cell oligos after the ligation of adapters.
Each fragment molecule is amplified isothermally in the clustering part. The
flow cell is a glass line with lanes. Each lanes is a channel coded with the com-
posed of two types of oligos. Complementary oligo to the adapter region on one
of the fragment strands, enables hybridization. A polymerase creates a comple-
ment of the hybridized fragment. The double stranded molecule is denatured
and the original template is washed away. The strands are amplified the bridge
amplification clonally. In this process the strands pulls over and the adapter
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region hybridizes to the second type of the oligo on the flow cell. The comple-
mentary strand is generated by polymerases forming a double stranded bridge
which is then denatured resulting in two single stranded copies of the molecule.
The process is then simultaneously repeated for millions of clusters resulting for
all fragments. Then, the reverse strands are washed away.
Figure 2.7: Illumina Machines. This figure is adapted from [8].
In the last part, sequencing, first sequencing primer is extended to produce
the first read. One of the 4 fluorescently tagged nucleotide is incorporated based
on the sequence of the template. After each incorporation, a light source is
used and a characteristic fluorescent signal is emitted. This process is known
as ”sequencing by synthesis”. The length of a read is determined by the cycle
number and the base call is determined by the emission wave length. Hundreds
of millions of clusters are sequenced in a massively parallel process. This entire
process generates billions of reads representing all the fragments. [10] [11]
2.2.2.4 IonTorrent
Workflow of Ion Torrent is comprised of library preparation, emulsion PCR,
and semiconductor sequencing processes. A hydrogen ion is naturally released
as a by-product, when a nucleotide is incorporated into a strand of DNA by a
polymerase.
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Ion Torrent works on the principle of detection of these hydrogen ion releases
in a massively parallel manner. These ions are detected on ion-semiconductor
sequencing chips. Ion Torrent technology creates a direct connection between the
chemical and digital events. [12]
Figure 2.8: IonTorrent Machines. This figure is adapted from [8]
2.2.3 Next Next Generation Sequencing (Third - Gener-
ation Sequencing Technology) (Single Molecule Se-
quencing)
Single molecule sequencing has ability to resequence the same molecule multi-
ple times for improved accuracy and the ability to sequence molecules that cannot
be readily amplified because of extremes of GC content, secondary structures, and
other reasons. The main focus of the molecule sequencing technology is gener-
ally on read length, error rate, and throughput. Potential for lower cost, higher
throughput, improved quantitive accuracy, and increased read lengths are offered
by single molecule sequencing. [13]
2.2.3.1 Pacific Biosciences (SMRT)
Pacific Biosciences (SMRT) that comprised of library preparation and sequenc-
ing processes is an example of single molecule sequencing. Pacific Biosciences
also developed a ”sequencing by synthesis” approach using fluorescently labeled
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nucleotides.
Figure 2.9: Pacific Biosciences Machine (SMRT). This figure is adapted from [8].
DNA is constrained to a small volume in a zero-mode wave guide and flu-
orescently labeled nucleotide near the DNA polymerase is measured because of
low capability of light penetration. Each nucleotide has a characteristic incor-
poration time which helps improving base calls. However, the raw error rate is
significantly higher than any other current sequencing technology. Therefore, it
creates challenges for variation detection. [13]
2.2.4 Fourth-Generation Sequencing Technology (Nanopore
Sequencing)
The results of fourth-generation sequencing technologies have not been suf-
ficiently evaluted yet because this is the newest sequencing technology and it
requires time. There is limited information about this technology for now.
2.2.4.1 Oxford Nanopore
Oxford Nanopore follows two parallel strategies. ”Exonuclease sequencing” is
the first one which based on exonuclease digestion of a single-stranded template
into nucleotides that are fed into a nearby protein nanopore in a lipid membrane.
”Strand sequencing” is the second strategy which is like feeding thread through
the eye of a needle.
16
Figure 2.10: MinION and GridION System.This figure is adapted from [8].
Detailed information about nanopore sequencing is not given here because it
requires time to be evaluated sufficiently. [8] [14]
2.3 Genome Sequencing
Genome sequencing can be divided into two categories that is defined below as
whole genome sequencing (WGS) and whole exome sequencing (WES).
Figure 2.11: Comparison of the size of whole genome and whole exome that are
found on human genome. This figure is adapted from [15].
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2.3.1 Whole Genome Sequencing
Whole genome sequencing (WGS) is a laboratory method that reads the exact
sequence of all DNA bases in an entire genome. The genome contains an indi-
vidual’s entire genetic code which means all of their genetic information. This
entire genetic code includes protein coding regions (exons as well as the areas
of the genetic code that do not give instructions for making proteins which are
non-coding DNA sequences (introns).
Figure 2.12: Sequencing
2.3.2 Whole-Exome Sequencing
All genomic regions coding for proteins and untranslated regions flanking them
form the exome of an organism. The exome comprises just over 1% of the genome
and 230,000 exons. It provides sequence information for protein-coding regions.
Most of the inherited disorders are believed to reside on the coding regions
so laboratories can focus exclusively on exon regions. It gives an opportunity to
eliminate the tremendous mass of non-coding DNA in the genome. The major
advantage of using WES instead of WGS data is using only 1-2% of human
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genome. The cost for sequencing is lowered significantly in this way. [1] [16]
The possibilities for analyzing exome has changed with NGS. In the past
years exome sequencing is widely used in gene discovery and the identification of
disease-causing mutations in pathogenic presentations in that the exact genetic
cause is not known. Rare mutations that change the function of a protein which
is the cause of most Mendelian and non-Mendelian diseases.
Almost half of the reported CNVs overlap with exon regions in DNA. There-
fore, usage of exome sequencing data is more sensible in terms of time and cost
efficiency. Most of the essential information about life mechanism of a human
body can be obtained with exome sequencing data so redundant data are not
necessarily processed.
Even though the reads have a non-uniform distribution, data can be improved
by the work discussed in this thesis and some related works [10] [17].
Figure 2.13: Workflow of whole exome sequencing. This figure is adapted from
[18].
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WES WGS
Target 50 Mb 3 Gb
Depth of Coverage Biased Poisson
Mapping Fast Slow
Analysis time Short Long
RD-based CNV discovery tools [1] 12 tools 15 tools
Cost $900 $5,000
Usage in CNV Discovery Less common due to biases Common
Table 2.2: Comparison of WES and WGS
2.4 Genomic Variations
Single nucleotide variants (SNPs), small insertions or deletions (indels), copy
number variations (CNVs), and large structural variants are called together as
genomic variation. [1]
2.4.1 Single Nucleotide
• Base change - substitution - point mutation: Substitution is a type
of mutation where one base pair is replaced by a different base pair.
• Insertion - deletions (indels): Indel describes relative gain or loss of a
segment in a genomic sequence.
2.4.2 2 bp to 1,000 bp
• Microsatellites: These sequences are composed of non-coding DNA and
they are not parts of genes. These are used as genetic markers to follow the
inheritance of genes in families.
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• Minisatellites: These are generally situated near genes and they are re-
peated segments of the same sequence of multiple triplet codons. Moreover,
minisatellites are useful as linkage markers due to their highly polymorphic
nature.
• Indels: Indel describes gain or loss of a segment in a genomic sequence.
• SNP/SNV: SNPs are a type of polymorphism which involves variation of
a single base pair.
• Variable Number Tandem Repeats - VNTRs: Linear arrangement
of multiple copies of short repeated DNA sequences that vary in length and
are highly polymorphic, making them useful as markers in linkage analysis.
2.4.3 1 kb to Submicroscopic
Figure 2.14: Classes of structural variation. This figure is adapted from [8].
• Copy number variants (CNVs): Copy number variants comprise of
deletions, insertions, and duplications. There is another term that is called
as CNP creating confusion. CNP is a CNV that occurs in more than 1%
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of the population. CNVs have been observed in the comparison of two or
more genomes.
– Copy number gain (insertions or duplications): A sequence
alteration whereby the copy number of a given region is greater than
the reference sequence.
– Copy number loss (deletions): A sequence alteration whereby the
copy number of a given region is less than the reference sequence.
• Segmental duplications: A segment of DNA >1 kb in size that occurs
in two or more copies per haploid genome, with the different copies sharing
>90% sequence identity.
• Translocation: A region of nucleotide sequence that has translocated to
a new position.
• Inversion: A continuous nucleotide sequence is inverted in the same posi-
tion.
• CNV regions (CNVRs): Merging of independently ascertained, but
overlapping, genomic segments creates the representation of a CNV locus.
2.4.4 Microscopic to Subchromosomal
• Segmental aneusomy: Disorder that results from the inappropriate
dosage of crucial genes in a genomic segment.
• Chromosomal deletions - losses: In this disorder, entire chromosomes,
or large segments of them, are missing.
• Chromosomal insertions - gains: In this disorder, entire chromosomes,
or large segments of them, are duplicated.
• Chromosomal inversions: In this disorder, entire chromosomes, or large
segments of them, are altered.
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• Intrachromosomal translocations: A segment breaks off the chromo-
some and rejoins it at a different location.
• Heteromorphisms: A chromosome pair with some homology but differing
in size, shape, or staining properties. Homologous chromosome pair which
are not morphologically identical (eg the sex chromosomes).
• Fragile sites: A chromosomal region that has a tendency to break.
2.4.5 Whole Chromosomal to Whole Genome
• Interchromosomal translocation: Recombination resulting from inde-
pendent assortment.
• Isochromosome: A chromosome with two genetically and morphologically
identical arms.
• Marker chromosomes: A structurally abnormal chromosome in which
no part can be identified.
• Aneuploidy : This is the state of having an abnormal number of chromo-
somes. Down syndrome is an example of aneuploidy.
• Aneusomy: is the condition in which an organism is made up of cells
that contain different numbers of chromosomes. [19] [2] [20]
2.5 The Effects of Copy Number Variations on
Human Health and Phenotype
A human carries two copies of most genes. One copy comes from mother
genome and one copy comes from father genome. Occasionally alterations in a
chromosome can lead to the gain or a loss of one copy. A deletion can occur when
a fragment of DNA is lost. It can occur either during copying or when the genes
are shuﬄes during meiosis. A duplication can occur whereby which we gain an
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additional copy of a gene by the same mechanisms. Deletions and duplications
of greater than 1,000 nucleotides are called copy number variants.
Figure 2.15: Tiger with down syndrome
A difference in the copy number of a gene can increase or decrease the level
of that genes activity so it may cause diseases, phenotypic changes or nothing.
For instance, when a copy of a gene is deleted, the cell may produce half as much
protein as compared to a normal cell. There are many diseases that are cause by
changes in gene copy number.
Next-generation sequencing technology is used to detect copy number varia-
tions in both healthy and diseased people. Although copy number variations do
not necessarily have a negative effect on human health, large number of CNVs
have an association with a disease or directly involve in. The most well-known
health problem because of CNV is Down Syndrome, which is caused by having
an extra copy of chromosome 21.
Some of the most known health problems due to CNVs are autism, schizophre-
nia, Turner syndrome, cancer, neuropsychiatric disorders, and obesity. Rare
CNVs may account for 15% of cases of pediatric neurodevelopmental diseases
Backenroth et al [21]. Although both rare and common CNVs are thought to
carry substantial risk for disease, much recent activity has focused on the role
played in disease by rare CNVs, given the smaller cohort sizes required to attain
statistical significance for identifying highly penetrant risk-associated rare CNVs.
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As another example, a recent study found that severe obesity is often associated
with a significant burden of large rare CNVs.
To comprehend the underlying causes of these in a less costly way, an efficient
sequencing approach is needed. Whole exome sequencing, the most cost-effective
way which is known, has the potential to rapidly detect copy number variations
that cause these things mentioned above in human coding regions.
WES has been commonly used in not only the detection of pathogenic variants
for Mendelian diseases, but also discovery of susceptible loci for complex diseases.
By using these kinds of approaches mentioned in this thesis, underlying causes
of some diseases and phenotypes and also the treatments of CNV-based diseases
can be found. [22] [19]
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Chapter 3
Finding Copy Number Variations
in Exome Sequencing Data
The steps required to find copy number variations in exome sequencing data
consist of mapping, correcting biases and normalization, estimation of copy num-
ber and segmentation parts. The main aim of the thesis is correcting some of the
biases in exome sequencing data, especially GC-content and probe efficiency.
3.1 Four-Step Procedure
Figure 3.1: Four-step procedure to find CNVs in WES data
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3.1.1 Mapping
Although human genome has a continuous structure to read, sequencing ma-
chines can only read a few hundred DNA letters at a time. These short DNA letter
sets are aligned to the reference genome. This causes some mapping problems
when these small reads are used for constructing whole part wanted. Mapping
is the first step to find CNVs so the problems in mapping affect the reliability
of the results. The choice of single or multiple mapping affects is one of these
effects. This choice can change copy number in some regions. It can either cause
unexpected increases or decreases in copy numbers.
Mapping are also affected by repeats in mapping part. Approximately 45% of
a human genome is repeats such as LINEs, SINEs, retrovirus-like elements, and
DNA transposon fosils. RepeatMasker program is available to identify repeats
for known ones, but this cannot identify all of these repeats.
3.1.2 Correcting Biases and Normalization
Systematic false positive and false negative results of exome sequencing are
identified. Mapping and systematic sequencing errors cause false positives. These
false positives are removed by comparing each sample against previously se-
quenced exomes so using more samples help to improve data. On the other
hand, low overall coverage, poor capture efficiency, and difficulty in unambigu-
ously aligning repetitive regions cause false negative results.
Other challenges also exist in this field. Reads have non-uniform distribution
and exome is not a continuous search space so this does not allow researchers
to use statistical approaches easily due to its sparse structure. This is generally
caused by different efficiency of exon capture probes. Another challenge is resolu-
tion limited by distance between exons. Some other challenges will be explained
below.
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Probe capture efficiency
Exome sequencing involves exon-capture step by which the coding regions
are selected from the total genome DNA by means of hybridization, either to
a microarray or in solution. The characteristics of the probe, such as length,
conformation and abundance on the solid phase, are of relevance in determining
the capture efficiency. Exon capture techniques are not efficient exactly because
3%-5% of the exons can’t be captured and sequenced. [16]
GC-content
GC-content is the percentage of guanine and cytosine bases in a genomic
region. It is higher in protein coding regions than intron regions of a genome.
GC abundance is heterogeneous across the genome and often correlated with
functionality.
GC content bias correction is a necessity for read-depth based copy number
detection tools. It was previously shown that there is a positive correlation be-
tween read depth and GC-content of a region. Average read depth of a region
has a unimodal relationship with its GC-content. Regions that have extremely
high or low GC-content might be excluded from the analysis. Bins with high or
low GC-content have lower mean read depth than bins with medium GC-content
due to the difference in probe efficiency and sequencing.
Most of the sequencing tools are affected by this bias so there are few tools
to correct GC-content bias.
Coverage
Multiple copies of a genome are randomly broken into small fragments.
Chunks of these fragments are sequenced, generating reads. Reads are merged
in regions that they overlap. Coverage is defined as the average number of reads
overlapping each base.
The majority of the reads form the final consensus sequence. The higher the
coverage of a consensus sequence segment, the more confident you can be in the
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accuracy of that segment.
Figure 3.2: High and low coverage
Coverage is calculated by the formula given below:
average coverage =
number of reads × read length
exon
Mapping
Next-generation sequencing generates short reads that are mapped to a ref-
erence genome and some of these reads, multi-reads, are not uniquely mapped
to the reference. The number of multi-reads depends on read lengths, allowed
number of mismatches, and choosing paired-end or single-end sequencing. On the
other hand, the presence of repetitive regions has also an effect on multi-mapping.
Figure 3.3: Multiple vs. unique mapping
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Polymerase Chain Reaction (PCR) Process
The PCR is an in vitro method for the enzymatic synthesis of specific DNA
sequences, using two oligonucleotide primers that hybridize to opposite strands
and flank the region of interest in the target DNA. In short, it represents a form
of ”in vitro cloning” that can generate, as well as modify, DNA fragments of
defined length and sequence in a simple automated and cyclic reaction.
One of the major cause of distortion in WES data is the PCR process. Less
reads are created when genomic fragments have lower PCR rates, which is also
affected by GC%.
3.1.3 Estimation of Copy Number
In the third step of read depth-based methods, the aim is to estimate accurate
copy numbers along the chromosome to determine gain or loss with the normalized
read depths. This step changes due to the sample size and selected path.
3.1.4 Segmentation
Segmentation is the process that combines all the reads from same continuous
region into a segment with determined boundaries. An ideal segmentation ap-
proach will merge adjacent data points with same copy number into one segment
and divide regions with different copy numbers into different segments. The copy
number state should also be evaluated for each region. The challenging part of
the segmentation is to separate random effects from copy number variations. [1]
3.2 Methods
Due to the increasing demand for copy number variation (CNV) detection, a
lot of algorithms have been appeared in the field. Choice of using whole genome
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sequencing-based (WGS-based) tools or whole exome sequencing-based (WES-
based) tools are mostly based on need in a research. However, WES-based tools
are getting more popular due to its efficiency in both cost and time.
Here is the table depicting types of variations that can be found by specific
tools. Read depth-based (RD-based) method is the main concern of this thesis
and duplications and deletions are the variation types that we want to find.
Finding CNVs
1-Paired-end (PE) mapping
2-Split read
3-Read depth (RD)
3.1-WGS
3.2-WES
3.2.1-Single sample
3.2.2-Paired case/control samples
3.2.3-A large population of samples4-Assembly-based
5-Hybrid approach
Figure 3.4: Classification of CNV detection methods
Some of the popular tools for CNV detection with using WES data are CON-
DEX [23], CONIFER [24], CONTRA, Control-FREEC, ExoCNVTest [25],
ExomeCNV, ExomeDepth [26], PropSeq [27], SeqGene, VarScan2, and XHMM
[28].
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SV classes Read pair Read depth Split read
deletion yes yes yes
novel sequence insertion yes no yes
mobile element insertion yes no yes
inversion yes no yes
interspersed duplication yes yes yes
tandem duplication yes yes yes
Table 3.1: Applicability of the tools to the methods
The quantitive relationship between true copy number and depth is distorted
by target-specific and sample-specific biases in capturing, PCR amplification, se-
quencing efficiency, and in silico read mapping, GC-content of the targets, target
size, sequence complexity, proximity to segmental duplications, single nucleotide
polymorphisms(SNPs), DNA concentration, hybridization temperature, experi-
mental sample batching, and various indeterminate factors. Hence, RD-based
methods using WGS data are not applicable to WES data if the extra biases
are not accounted for. Moreover, the assumption of normal distribution may no
longer be valid due to the biases regarding read depth distribution and most of
the CNV breakpoints could not be detected due to the discontinuation of genomic
regions. Lastly, the widely applied segmentation algorithms to merge windows in
WGS may not be applicable due to the non-continuous distributions of the reads
in WES data.
3.2.1 Paired-end mapping (PEM)-based methods
Finding CNV using NGS data was first made by PEM methods that can only
applied to paired-end reads. PEM-based method is based on identification of
CNVs from discordantly mapped paired-reads whose distances are significantly
different from the predetermined average insert size.
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Figure 3.5: Paired-end mapping-based methods
In addition to insertions and deletions, this is also used for identification of
mobile element insertions, inversions, and tandem duplications. However, this is
not applicable for insertion events which are larger than the average insert size.
There are two different approaches in PEM methods which are the clustering
approach in which predefined distance is provided and the model-based approach
in which statistics is used to define a distance.
Unlike WGS data, the non-random nature of reads from WES limit the appli-
cability of PEM-based methods for CNV discovery. For instance, the insert size
for paired-end reads in WES data may not be long enough to detect CNV. The
PE reads should span the CNV breakpoints, but they may not be within exons,
thus not captured.
3.2.2 Split read-based methods
Split read-based (SR-based) methods are conceptually used to find insertions
and deletions (indels). These methods use read pairs. First read is aligned to the
reference genome uniquely while the other read fails to map or maps partially to
the reference genome.
Figure 3.6: Split read-based methods
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The breakpoints of structural variations (SVs) are provided due to these un-
mapped or partially mapped reads. The incompletely mapped reads are splitted
into fragments in SR-based methods. First and last parts of these fragments
are aligned to the reference genome and the exact start and end positions are
found. SR-based methods can only be applied to the unique regions based on
read length.
In contrast to whole genome sequencing (WGS) data, whole exome sequencing
(WES) results in nonuniform read depth (RD) between the captured regions and
systematic biases that affect data strongly between batch of samples. The split
reads should also span the CNV breakpoints, but they may not be within exons,
thus not captured. These biases and the sparse nature of the capture make WES
unsuitable for well-known CNV detection algorithms [29] [30] [24].
3.2.3 Read depth-based methods
This is the most common approach to estimate copy number due to the ac-
cumulation of next generation sequencing (NGS) data. The most appropriate
method between these 5 categories to find copy number variations (CNVs) with
the help of whole exome sequencing (WES) data is the based on read depth (RD).
Depth of coverage, also known as coverage, is calculated by counting the
number of reads which cover each base and then calculating their average for
each target. RD-based methods are rely on the correlation between the depth of
coverage in a genomic region and the copy number of that region. If there is higher
count than expected, then there is a duplication in a region. On the contrary,
there is a deletion if there is lower count than expected in a region. Exact copy
numbers, CNV in complex genomic region classes, and large insertions can be
found with the usage of RD-based methods.
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Figure 3.7: Calculation depth of coverage
Two major next-generation sequencing approaches, WES and WGS, are used
to detect CNVs. If WGS-based tools are used theoretically, the full spectrum of
variant can be detected. However, WES-based tools are more effective in terms
of time and cost efficiency.
Figure 3.8: Read depth-based method
RD-based methods are classified into 3 categories in terms of the sample size:
single sample, paired case/control samples, and a large population of samples.
In single sampled-studies the aim is to estimate the read depth distribution us-
ing mathematical models and detect the regions with abnormal depth different
from the overall distribution. In the second type of method, paired case/control
samples, control sample are thought as a reference genome and copy numbers
in case sample are reported as relative copies compared to the control sample.
These copy numbers are not exact copy numbers. For large population of samples
cases, the overall mean of the read depth from multiple samples are used to detect
the discordant copy numbers in each sample. This method generally reflects the
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exact copy numbers.
CNV discovery from WES data is challenging because of the non-contiguous
nature of captured exons (All exons cannot be detected by current technologies).
This challenge is compounded by the complex relationship between read depth
and copy number which is affected by biases in targeted genomic hybridization,
sequence factors such as GC-content, and batching of samples during collection
and sequencing. Approaches based on Gaussian and other popular distributions
used in CNV detection with using WGS data are not working on CNV detection
tools with using WES data due to biases and indeterminate factors.
3.2.4 Assembly-based methods
Firstly, contigs are constructed by using DNA fragments and compared them
to the reference genome as a guide. The genomic regions with discordant copy
numbers are determined in this way.
Figure 3.9: Assembly-based methods
These kinds of methods propose an unbiased approach to detect novel variants
from single base to large structural variations, but these are generally used for the
other small-sized genomes due to their huge demand on computational resources.
In AS-based methods, reads should also span the CNV breakpoints, but they
may not be within exons, thus not captured. These biases mentioned above and
the sparse nature of the capture make WES unsuitable for AS-based methods.
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3.2.5 Hybrid approaches
Two or more approaches mentioned above are used together in this approach.
Though there has been a great progress in each of these approaches mentioned
above, none of them is able to detect all variants in a genome precisely.
Each of the methods above has its own advantages and disadvantages so
taking advantages creates need to combine some of these methods to increase
the performance in detecting variants and reduce false positive rates. [1]
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Chapter 4
Related Works
4.1 Whole Genome Sequencing
4.1.1 Summarizing and Correcting the GC Content Bias
in High-Throughput Sequencing
GC content bias is explained as the dependence between read coverage and GC
content found on Illumina sequencing data. This bias is not consistent between
samples and there is no consensus to find the best method to remove this bias in a
single sample. In this paper, a model that produces predictions at base pair level,
allow strand-specific GC-effect correction regardless of the downstream smoothing
or binning is presented.
Most current correction methods follow a common path. Fragment counts
and GC counts are binned to a chosen bin-size. A curve that describes the condi-
tional mean fragment count per GC value is estimated. This curve determines a
predicted count for each bin based on the bin’s GC. These obtained predictions
can be used to normalize the original signal directly. These methods do not use
any prior knowledge about the effect whereas they remove most of the GC effect.
A descriptive approach to investigate the common structures that is found in
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GC curves of DNA sequencing data is described in this work. The effect of GC on
fragment count for many high coverage human genomes which are from different
labs is studied. Copy numbers for normal genomes change rarely so observed
variability in fragment count may always be attributed to technical effects rather
than biological effects. A single position model is used to estimate the effect of
GC on the fragment counts.
LOESS method is used by them. First, read depth and GC content are
calculated for each bin. The GC bias curve is determined by loess regression of
count by GC on a random sample of 10000 high mappability (> 0.9) bins. The
smoothness parameter, also known as span, for the LOESS should be tuned to
produce curves that are smoothing but still capture the main trend in data. This
parameter is estimated as 0.3 in this work.
Unlike the other bias correction methods, such as BEADS, predicted fragment
rates for the genomic location rather than for the observed reads are generated.
[31]
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4.2 Whole Exome Sequencing
4.2.1 Copy Number Variation Detection and Genotyping
from Exome Sequencing Data
Copy number inference from exome reads (CoNIFER) is a novel method that
uses singular value decomposition (SVD) normalization to discover rare genic
copy number variants (CNVs) as well as genotype copy number polymorphic
(CNP) loci with high sensitivity and specificity from whole exome sequencing
(WES) data. It can be used to discover disruptive genic CNVs that are missed
by standard approaches reliably. In this study both read depth (RD) data from
WES data with SVD methods to discover rare CNVs and genotype known CNP
regions from HapMap samples are combined.
The workflow of CoNIFER starts with dividing fastq-formatted WES reads
into non-overlapping 36 base paired-sets and aligning them to the targeted re-
gions. These reads are aligned by allowing up to two mismatches per each read
set. Reads per thousand bases per million reads sequenced (RPKM) values are
calculated and then these are transformed into ZRPKM values, RPKM values
transformed into standardized z-scores, based on the median and standard devi-
ation of each exon across all samples. ZRPKM values are used as input for the
SVD transformation. The strongest k singular values that depends on data are
removed. SVD normalization is used to overcome coverage biases introduced by
the capture and sequencing of exomes. [24]
4.2.2 Discovery and Statistical Genotyping of Copy Num-
ber Variation from Whole Exome Sequencing Depth
Exome hidden Markov model (XHMM) is a statistical tool that uses princi-
pal component analysis (PCA) to normalize exome read depth and uses hidden
Markov model (HMM) to discover exon-resolution CNV and genotype variation
across samples.
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The workflow of XHMM starts with aligned exome read BAM-formatted files.
Firstly, depth of coverage is calculated. PCA is run on the sample-by-target-
depth matrix by rotating the high dimensional data to find the main components
in which depth varies across multiple samples and targets and some of the largest
effects that depends on data are removed. Normalized data is trained and HMM
is run to discover CNVs spanning adjacent targets. At the end of the process,
CNV calls and genotype qualities for all samples is outputted.
The main limitation of XHMM tool is the requirement of large number of
samples because of the PCA normalization step. The efficiency of PCA depends
on data size. [28]
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Chapter 5
Description of the Experiments
5.1 Data
In this thesis, the correlation between read depth, GC content, and probe
efficiency is systematically evaluated using 1000 genomes data. We tested our
methods on 7 samples from different populations around the world. Samples,
HG00629, HG01191, HG01437, NA19664, NA19707, NA19723, and NA20766,
are chosen randomly between the other samples of 1000 genomes project. These
samples data were created by using the Illumina HiSeq2000 sequencing technol-
ogy. Whole genome sequencing data is mapped to the exon regions in human
genome (version hg19) so the data are used as whole exome sequencing data with
this way. The Agilent Sure Select Capture Kit annotation was used to capture the
exomes in the data we analyzed. There are also different whole exome capturing
tools like Illumina TrueSeq Capture Kit. Although other capture kit annotations
haven’t been tested by using our method, our method can also be used for them
theoretically.
The gene positions are token from UCSC Genome Browser refFlat (hg19)
data. Probe efficiency, average of GC-content, and read depth are calculated
for each gene by using these positions and exon information included by these
genes. Known common deletions, duplications, and low-coverage regions of 1000
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Genomes data found in this work are used to remove data noise as much as
possible.
We only analyzed the autosomal chromosomes (i.e. no sex chromosomes).
5.2 Mapping
5.2.1 Mapping of Reads to the Reference: MrsFAST-
Ultra
Although increasing read lengths, the mapping step remains as an important
problem. The accuracy of found structural variants are partially related to this
step. Tools that report the best mapping location for each read are not appro-
priate for structural variation detection where it is important to report multiple
mapping loci for each read. MrsFast fills this gap as a fast, cache oblivious,
and SNP-aware aligner that can handle the multi-mapping of next-generation
sequencing reads efficiently.
MrsFAST is a mapping algorithm that rapidly finds all mapping locations of
a collection of short reads from a donor genome in the reference genome within
a user-specified number of mismatches. It is specifically designed for reads gen-
erated by Illumina sequencing machines.
Two main steps are included in the tool. The first step consists of building
an index from the reference genome for exact anchor matching. The second step
consists of computing all anchor matching for each of the reads in the reference
genome through the index, extends each match to both left and right and checks
if the overall alignment is within the user defined error threshold.
The mapping task is simply partitioned into independent threads executed
by a single-core which is defined by user. Multi-thread option is used as using 8
threads in this work. Moreover, paired-end mode is preferred because of the reads
used in this work. Owing to the repetitive content of human genome sequence,
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the most comprehensive assemblies are derived from paired-end reads, where the
sequence reads are obtained from both ends of each DNA fragment. Disable-
nohits option is selected to speed up the process to prevent the accumulation of
useless data. As a reference the hg19 version of human genome is selected. [32]
5.2.2 Calculation of read depth: Bedtools
Bedtools is introduced for comparison, manipulation, and annotation of ge-
nomic features in different file formats. Bedtools is used frequently in different
steps of this work. Firstly, the output of MrsFast is sam-formatted and the
input required to use count option of bedtools is bed-formatted. Therefore, sam-
formatted files are converted into the bed-formatted files.
Common low-coverage regions, deletions, and duplications of the 1000 genome
samples are removed and the remaining parts are assumed as normal. The exon
coordinates of the Agilent Sure Select Capture Kit annotation is used as the
reference to find read-depths of each region. Read counts for each exon is calcu-
lated to find read depths. This process is done by using count option of bedtools
intersect.
5.2.2.1 Common Data File Formats
Sequence Alignment/Map Format (SAM): SAM format is used to store
read alignments against reference sequences. It supports short and long reads
which are produced by different sequencing platforms including Illumina. It also
supports single-end and paired-end reads and combining reads of different types,
including color space reads from ABI/SOLiD.
Binary Alignment/Map Format (BAM): BAM format is the binary repre-
sentation of SAM format and keeps exactly the same information as SAM. It is
designed to improve the performance. It is the compact version of SAM format.
It is used in a common way.
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Browser Extensible Data Format (BED): BED format is an exact and
flexible way to represent genomic features and annotations. With the help of the
bedtools and some other similar tools, this format ease bioinformaticians’ work.
Variant Call Format (VCF): VCF is a generic format which is used to store
most prevalent forms of DNA polymorphisms including SNPs, insertions, dele-
tions, and large structural variants together with rich annotations. This format
is provided to use in 1000 genomes data processes. VCF format is also used to
comprehend 1000 genomes data in this work. [33] [34] [35]
5.3 Correcting Biases and Normalization
Systematic errors are platform-dependent. In the context of this work, we
focus on Illumina data. Current studies about Illumina data evaluation have re-
vealed several biases, a non-random distribution of reads in the sequenced sample
over the reference and a non-random distribution of errors. Although there are
some popular works to correct GC-content bias, there is no work to correct probe
efficiency bias of exome sequencing data.
The aim of this work is to solve the probe efficiency bias in exome sequencing
data and make the popular finding copy number variation tools work with correct
results. Understanding of the relationship between GC-content, probe efficiency
biases, and read depth is required to accomplish this aim. In this part, the effect
of both GC-content and probe efficiency will be evaluated together.
Correlation
Correlation coefficient is used to understand the relationships between dif-
ferent data sets. These data sets can be composed of two or more. In this part,
correlation between two data sets will be discussed.
Simple correlation coefficient is represented by r. Positive correlation coeffi-
cient means that both values increase together and negative correlation coefficient
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means that one of these values increases while the other value decreases. Addi-
tionally, there is no relationship between them if correlation coefficient equals
zero. [36]
In this work, correlation coefficient is used to understand the relationship
between read depth and GC-content and the relationship between read depth
and probe efficiency. Correlation coefficient is calculated by the formula below:
rrd,pr =
∑n
i=1 (rdi−rd)(pri−pr)√∑n
i=1 (rdi−rd)2
∑n
i=1 (pri−pr)2
rrd,gc =
∑n
i=1 (rdi−rd)(gci−gc)√∑n
i=1 (rdi−rd)2
∑n
i=1 (gci−gc)2
Multiple Correlation
Multiple Correlation measures the amount of linear association between
one dependent variable and more than one independent variables. It is an ex-
tension of simple correlation (frequently just called as correlation). It helps to
determine whether if more than one independent variable should be included in
the model. Multiple Correlation Coefficient is represented by R and calculated
by the formula below:
Ry,x1,x2 =
√
ryx1
2+ryx2
2−2ryx1ryx2rx1x2√
1−r2x1x2
where y is the dependent variable, x1 and x2 are the independent variables, ryx1
is the correlation coefficient between y and x1, ryx2 is the correlation coefficient
between y and x2, and rx1x2 correlation coefficient between x1 and x2.
In this work, independent variables are GC-content and probe efficiency while
dependent variable is read depth. Adapted version of multiple correlation formula
to our work is demonstrated below:
Rrd,pr,gc =
√
rrd,gc2+rrd,pr2−2rrd,gcrrd,prrgc,pr√
1−r2gc,pr
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where rd is the dependent variable, pr and gc are the independent variables,
rrd,gc is the correlation coefficient between read depth and GC content, rrd,pr is
the correlation coefficient between read depth and probe efficiency, and rgc,pr is
the correlation coefficient between GC content and probe efficiency.
Smoothing data (LOESS)
LOESS method uses locally weighted linear regression to smooth data. It is
a regression model, no parameter needs to be estimated except the smoothness.
The smoothness parameter, also known as span, for the LOESS should be tuned
to produce curves that are smooth but still capture the main trend in data.
A span represents the percentage of the data in which we are interested. This
span value determines the smoothness of the curve and is chosen between 0 and
1. Each value is smoothened by using neighboring data within the span so this
method is local.
The size of span has an important effect on the curve. If a span is too small,
it produces a curve characterized by a lot of noise. If a span is too large, the
regression will be over-smoothened and thus the local polynomial may not fit the
data well. This will result in high variance. The weight function is also defined
for the data within this span. This will result in loss of information and the fit
will have large bias. Therefore, the tradeoff between bias and variance should be
well-evaluated.
The degree of polynomial has also effects on the curve. A higher degree
provides a better approximation and less bias. On the other hand, it requires
more coefficients to estimate. The best strategy is to choose lower degree of
polynomial and concentrate on choosing best bandwidth.
The weight function to be chosen has less effect than the other things men-
tioned above. The most chosen weight function is the tricube weight function.
LOESS procedure is similar to what is commonly used in local regression. It
is assumed that the data are generated by the function below:
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yi = g(xi) + i
where g is a smoothing function of the independent variables. The aim is to
find smoothing function.
Constructing LOESS curve procedure:
1. Let xi denote a set of n values for a predictor variable and let yi represent the
corresponding response.
2. Choose a span value (α) between 0 and 1. Let k be the greatest integer less
than or equal to α× n.
3. Find the k points for each x0 in the data set that are closest to x0. These xi
comprise a neighborhood of x0, and this set is denoted by N(x0).
4. Compute the distance of the xi in N(x0) that is the furthest away from x0
using
∆k(x0) = maxxi∈N0|x0 − xi|
5. Assign a weight function to each point (xi, yi), xi ∈ N0, using the tri-cube
weight function:
w(x) =
{
(1− |x|3)3 for |x| < 1
0 for |x| ≥ 1
6. Obtain the value y0 of the curve at the point x0 for the given α using a weight
least squares fit of the points xi in the neighborhood N(x0).
7. Repeat steps 3 through 6 for all x0 of interest. [37]
After smoothing the data, correlation improves. However, calculating corre-
lation after smoothing gives false positive results in this way. If smoothing is
done first, the burden of carrying through the uncertainty of that smoothing to
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the estimated correlations will appear, which will be far less certain than when
computed for unsmoothed data. Smoothing induces spurious correlations.
5.3.1 Calculation of Correlation Coefficients for Each
Exon Region
To understand the relationship between read depth, GC-content and probe
efficiency correlation coefficients for each exon are calculated.
Samples Rd and Pr Rd, Pr, and GC
HG00629 0.6478 0.7118
HG01191 0.6375 0.7095
HG01437 0.6483 0.6708
NA19664 0.6383 0.6640
NA19707 0.6484 0.6733
NA19723 0.6508 0.6751
NA20766 0.6509 0.6768
Table 5.1: Correlation between read depth, probe efficiency and GC content for
each exon
In a recent study of the Illumina HiSeq and Genome Analyzer systems, [36] a
positive correlation between read depth and GC-content was observed when GC
percentage is within the spectrum of 24% to 47%.
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Samples Rd and Pr Rd, Pr, and GC
HG00629 0.79404 0.7959
HG01191 0.78969 0.7899
HG01437 0.76086 0.7644
NA19664 0.75367 0.7568
NA19707 0.76771 0.7713
NA19723 0.76126 0.7650
NA20766 0.77169 0.7752
Table 5.2: Correlation between read depth, probe efficiency and GC content for
each exon (0.24<GC Content<0.47)
Starting from this point of view, the data were also evaluated within this
interval and the increase in the positive correlation coefficient was observed.
It is expected that the values of probe efficiency and read depth are directly
proportional and almost on a linear fit line and the graphics almost meets the
expectation. However, there are lots of outliers seen on the graphs.
Figure 5.1: Read depth and probe efficiency for each exon
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Data points are not on a linear line in the graphics due to the other biases,
such as mapping errors, and the possibility of being copy number variations.
First of all, we evaluate the effect of the GC-content. We then re-calculate
exons of which GC-content is within the spectrum of 24 to 47%.
Figure 5.2: Read depth and probe efficiency for each exon (0.24<GC
Content<0.47)
As it is expected statistically, read depth and GC-content data points have
graphics like below.
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Figure 5.3: Read depth and GC content for each exon
5.3.2 Calculation of Correlation Coefficients for Each
Gene Region
The possibility of reducing noises in data by using genes regions of genome
is evaluated. To understand the relationship between read depth, GC-content
and probe efficiency correlation coefficients for each genes are also calculated. All
exons in each gene are expected to have almost the same characteristics.
Starting from this expectation, the usage of genes’ and exons’ information are
evaluated separately. As a result, using gene information increases the correlation
coefficient positively.
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Samples Rd and Pr Rd,Pr, and GC
HG00629 0.9011 0.9134
HG01191 0.8885 0.9037
HG01437 0.9170 0.9274
NA19664 0.9140 0.9248
NA19707 0.9146 0.9256
NA19723 0.9151 0.9262
NA20766 0.9163 0.9273
Table 5.3: Correlation between read depth, probe efficiency and GC content for
each gene
Using the idea of the recent study of the Illumina HiSeq and Genome Ana-
lyzer systems mentioned above, [36] the correlation between read depth, probe
efficiency, and GC-content were observed when GC percentage is within the spec-
trum of 24% to 47%. It was concluded with the same thing that the increase in
the positive correlation coefficient is observed.
Samples Rd and Pr Rd,Pr, and GC
HG00629 0.9809 0.9814
HG01191 0.9787 0.9804
HG01437 0.9698 0.9732
NA19664 0.9709 0.9738
NA19707 0.9704 0.9737
NA19723 0.9697 0.9732
NA20766 0.9715 0.9748
Table 5.4: Correlation between read depth, probe efficiency and GC content for
the genes (0.24<GC Content<0.47)
The evaluation of each exon separately affects the relationship of GC-content
and read depth. Due to the increase in correlation coefficients when using gene
information, it is expected that most of the data should be on a linear line.
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Figure 5.4: Read depth and probe efficiency for each gene
Using the same idea of the study mentioned above, [36] the correlation be-
tween read depth, probe efficiency, and GC-content were observed when GC per-
centage is within the spectrum of 24 to 47%. It was concluded with the same
thing that the increase in the positive correlation coefficient is observed for genes’
information.
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Figure 5.5: Read depth and probe efficiency for each gene (0.24<GC
Content<0.47)
After these corrections, there are also some outliers on the graphs. Most of
these outliers probably belong to copy number variations and some other biases.
To see the big picture, all processes for each sample are showed in the figures
below. As seen, all of them are almost in the same manners for each process. Some
differences may be seen because of the process in the sequencing part, different
diseases and phenotypes that they have, and some other things like these.
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Figure 5.6: a. Read depth and probe efficiency of HG00629 for each exon b.Read
depth and probe efficiency of HG00629 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of HG00629 for each gene d. Read depth
and probe efficiency of HG00629 for each gene (0.24 < GC-Content < 0.47)
Figure 5.7: a. Read depth and probe efficiency of HG01191 for each exon b.Read
depth and probe efficiency of HG01191 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of HG01191 for each gene d. Read depth
and probe efficiency of HG01191 for each gene (0.24 < GC-Content < 0.47)
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Figure 5.8: a. Read depth and probe efficiency of HG01437 for each exon b.Read
depth and probe efficiency of HG01437 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of HG01437 for each gene d. Read depth
and probe efficiency of HG01437 for each gene (0.24 < GC-Content < 0.47)
Figure 5.9: a. Read depth and probe efficiency of NA19664 for each exon b.
Read depth and probe efficiency of NA19664 for each exon (0.24 < GC-Content
< 0.47) c. Read depth and probe efficiency of NA19664 for each gene d. Read
depth and probe efficiency of NA19664 for each gene (0.24 < GC-Content < 0.47)
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Figure 5.10: a. Read depth and probe efficiency of NA19707 for each exon b.Read
depth and probe efficiency of NA19707 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of NA19707 for each gene d. Read depth
and probe efficiency of NA19707 for each gene (0.24 < GC-Content < 0.47)
Figure 5.11: a. Read depth and probe efficiency of NA19723 for each exon b.Read
depth and probe efficiency of NA19723 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of NA19723 for each gene d. Read depth
and probe efficiency of NA19723 for each gene (0.24 < GC-Content < 0.47)
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Figure 5.12: a. Read depth and probe efficiency of NA20766 for each exon b.Read
depth and probe efficiency of NA20766 for each exon (0.24 < GC-Content < 0.47)
c. Read depth and probe efficiency of NA20766 for each gene d. Read depth
and probe efficiency of NA20766 for each gene (0.24 < GC-Content < 0.47)
5.3.3 Finding optimum span parameter of LOESS method
Span parameter is represented by α and it defines the interval to be contained
in the calculation for each data point. Choice of span value depends on data
size and distribution of data. α value is chosen between 0 and 1. For example,
10% of the data is used when α = 0.1. Starting from this point, the smoothened
data will be overfitted when α goes to 1. In contrast, the smoothed data will be
underfitted when α goes to 0.
Finding the optimal value is the most difficult part of using the LOESS
method. For the case of this work, data for all genes don’t require a great changes
because most of the data is on the fit line. Therefore, the span value α was chosen
as 0.05 after trying different span values.
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Figure 5.13: Smoothed read depth and probe efficiency by LOESS method for
each gene (HG00629 (Span=0.001) )
Figure 5.14: Smoothed read depth and probe efficiency by LOESS method for
each gene (HG00629 (Span=0.05) )
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Figure 5.15: Smoothed read depth and probe efficiency by LOESS method for
each gene (HG00629 (Span=0.9) )
Figure 5.16: Smoothed read depth and probe efficiency by LOESS method for
each gene (HG00629 (Span=0.005) )
There is another LOESS method that is known as Robust LOESS. This
method is also tried, but it doesn’t give results better than LOESS method.
This method is more appropriate when there are many outliers.
63
Figure 5.17: Smoothed read depth and probe efficiency by Robust LOESS method
for each gene (HG00629 (Span=0.005) )
Correlation coefficients are calculated for smoothed samples’ data and coef-
ficient values are increased so there is a strong relationship between read depth
and probe efficiency like read depth, probe efficiency, and GC content. However,
increases of multiple correlation coefficients for all genes and genes having speci-
fied GC-percentage between 24% and 47% are little or nothing. Therefore, they
don’t require special interest. That’s why we just correct read depth and probe
efficiency with using LOESS method for genes at the end.
Samples Rd and Pr Rd, Pr, and GC
HG00629 0.9806 0.9865
HG01191 0.9721 0.9802
HG01437 0.9756 0.9779
NA19664 0.9754 0.9782
NA19707 0.9741 0.9768
NA19723 0.9746 0.9773
NA20766 0.9758 0.9784
Table 5.5: Correlation between read depth, probe efficiency and GC content for
each smoothed gene data
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Using the idea mentioned above, [36] the correlation between read depth,
probe efficiency, and GC-content were observed when GC percentage is within
the spectrum of 24% to 47% for gene. It was concluded with the increase in the
positive correlation coefficient after smoothing data.
Samples Rd and Pr Rd, Pr, and GC
HG00629 0.9921 0.9989
HG01191 0.9960 0.9968
HG01437 0.9915 0.9942
NA19664 0.9921 0.9944
NA19707 0.9907 0.9931
NA19723 0.9907 0.9934
NA20766 0.9911 0.9934
Table 5.6: Correlation between read depth, probe efficiency and GC content for
each smoothed gene data (0.24 < GC Content < 0.47)
LOESS method was applied to all samples demonstrated in the next page and
it improved the data.
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Figure 5.18: Smoothed read depth and probe efficiency by LOESS method for
each gene
LOESS method was applied to samples whose GC-percentage is within the
spectrum of 24% to 47% demonstrated below and it gives better results.
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Figure 5.19: Smoothed read depth and probe efficiency by LOESS method for
each gene
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Chapter 6
Conclusion
Due to its lower cost and higher throughput, exome sequencing is to find
genetic causes for common diseases. Whole exome sequencing has the potential
to detect copy number variations rapidly. However, whole exome sequencing has
some limitations because it covers approximately 1% of whole genome.
As a result of covering limitations, the full spectrum of CNVs and breakpoints
cannot be completely characterized and large CNVs cannot be detected precisely.
On the other hand, whole exome sequencing data gives a quick insight into copy
number variation patterns for a specific disease and phenotype.
Whole exome sequencing data have higher depth for targeted regions in con-
trast to whole genome sequencing data. Higher read depth is ideal for more
accurate copy number variations using read depth-based methods which is men-
tioned in this work.
Due to different capture efficiency, the depth from different genomic regions
may vary substantially. These different capture efficiencies should be normalized.
Our aim is to minimize this capture efficiency bias as much as possible. There
are no methods that claims that can correct all biases in sequencing data. All
methods (or algorithms) about finding copy number variations have their own
advantages and disadvantages. The choice of tool is dependent on the aim of
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research.
6.1 Future Work
There have been substantial improvements on both sequencing and calling
variations. New sequencing technologies have appeared in the field recently.
There are some studies that use third generation sequencing and they offer longer
reads that will greatly ease read alignment and CNV detection in repetitive re-
gions of genome and significantly reduce mapping errors due to incorrect sequenc-
ing. The increased size of short read will also strengthen the statistical power of
read depth-based (RD-based) methods. Although fourth generation sequencing
technology, such as Oxford Nanopore, has also appeared, the reliability of this
new technology is not yet known. More research on this technology is needed to
decide whether if it is reliable or not.
In this thesis, only autosomal chromosomes are investigated because sex chro-
mosomes and the other chromosomes are needed a special interest due to their
distinctive structures. As an improvement, other kinds of chromosomes can also
be investigated.
As a future work of this thesis, a tool will be developed using corrections
mentioned in this work. The improvements, discussed in the thesis, on exome
sequencing data will be used in the tool that we have developed. Only two
steps of whole procedures of finding copy number variations using whole exome
sequencing data are worked on and the remaining two steps should be done.
Tools used in detecting CNVs are really hard to use even the popular ones so
there is a need for new tools in this field. By using the corrected and normalized
exome sequencing data in one of the appropriate semi-supervised or supervised
learning algorithms chosen due to labeled data size copy numbers can be found.
In the last step of the procedure, one of the standard segmentation algorithms
can be applied or a new segmentation algorithm can also be developed. Exome
sequencing is a special form of targeted sequencing so this new developed tool
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can be adapted to any type of targeted sequencing, such as molecular inversion
probe (MIP) based targeting. If successful tools we plan to develop using the
methods presented in this thesis may also be used in clinical sequencing tests
that we expected to be used in all hospitals within the next few years. [38]
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Appendix A
Glossary
BAM: Binary Aligment/Map Format
BEADS: Bias Elimination Algorithm for Deep Sequencing
BED: Browser Extensible Data Format
CNP: Copy Number Polymorphism
CNV: Copy Number Variation
dATP: deoxyAdenosine TriPhospate
dCTP: deoxyCytidine TriPhospate
dGTP: deoxyGuanosine TriPhospate
dTTP: deoxyThymidine TriPhospate
DNA: Deoxyribonucleic Acid
Indel: Insertion and Deletion
Kb: Kilo base
LINE: Long Interspersed Elements
LOESS: Locally Weighted Regression Scatter Plot Smoothing Method
Mb: Mega base
NGS: Next-Generation Sequencing
PCA: Principal Component Analysis
PCR: Polymerase Chain Reaction
PE: Paired-End
SAM: Sequence Alignment/Map Format
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SE: Single-End
SINE: Short Interspersed Elements
SNP: Single Nucleotide Polymorphism
SV: Structural Variation
VCF: Variant Call Format
VNTR: Variable Number Tandem Repeats
WES: Whole Exome Sequencing
WGS: Whole Genome Sequencing
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Appendix B
Length measurements
The following abbreviations are commonly used to describe the length of a DNA
molecule:
bp := One base pair corresponds to roughly 618 or 643 daltons (the standard
unit that is used for indicating mass on an atomic or molecular scale) for DNA.
kb (kbp) := kilo base pairs = 1, 000 bp.
Mb := mega base pairs = 1, 000, 000 bp.
Gb := giga base pairs = 1, 000, 000, 000 bp.
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Appendix C
Timeline of DNA
1865: Gregor Mendel discovers through breeding experiments with peas that
traits are inherited based on specific laws (later to be termed ”Mendel’s laws”).
1866: Ernst Haeckel proposes that the nucleus contains the factors responsible
for the transmission of hereditary traits.
1869: Friedrich Miescher isolates DNA for the first time.
1871: The first publications describing DNA (”nuclein”) by Friedrich Miescher,
Felix Hoppe-Seyler, and P. Plo´sz are printed.
1882: Walther Flemming describes chromosomes and examines their behavior
during cell division.
1884 - 1885: Oscar Hertwig, Albrecht von Ko¨lliker, Eduard Strasburger, and
August Weismann independently provide evidence that the cell’s nucleus contains
the basis for inheritance.
1889: Richard Altmann renames ”nuclein” to ”nucleic acid.”
1900: Carl Correns, Hugo de Vries, and Erich von Tschermak rediscover Mendel’s
Laws.
1902: Theodor Boveri and Walter Sutton postulate that the heredity units
(called ”genes” as of 1909) are located on chromosomes.
1902 - 1909: Archibald Garrod proposes that genetic defects result in the loss
of enzymes and hereditary metabolic diseases.
1909: Wilhelm Johannsen uses the word ”gene” to describe units of heredity.
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1910: Thomas Hunt Morgan uses fruit flies (Drosophila) as a model to study
heredity and finds the first mutant (white) with white eyes.
1913: Alfred Sturtevant and Thomas Hunt Morgan produce the first genetic
linkage map (for the fruit fly Drosophila).
1928: Frederick Griffith postulates that a ”transforming principle” permits prop-
erties from one type of bacteria (heat-inactivated virulent Streptococcus pneumo-
niae) to be transferred to another (live nonvirulent Streptococcus pneumoniae).
1929: Phoebus Levene identifies the building blocks of DNA, including the four
bases adenine (A), cytosine (C), guanine (G), and thymine (T).
1941: George Beadle and Edward Tatum demonstrate that every gene is respon-
sible for the production of an enzyme.
1944: Oswald T. Avery, Colin MacLeod,and Maclyn McCarty demonstrate that
Griffiths ”transforming principle” is not a protein, but rather DNA, suggesting
that DNA may function as the genetic material.
1949: Colette and Roger Vendrely and Andre´ Boivin discover that the nuclei of
germ cells contain half the amount of DNA that is found in somatic cells. This
parallels the reduction in the number of chromosomes during gametogenesis and
provides further evidence for the fact that DNA is the genetic material.
1949 - 1950: Erwin Chargaff finds that the DNA base composition varies be-
tween species but determines that within a species the bases in DNA are always
present in fixed ratios: the same number of A’s as T’s and the same number of
C’s as G’s.
1952: Alfred Hershey and Martha Chase use viruses (bacteriophage T2) to con-
firm DNA as the genetic material by demonstrating that during infection viral
DNA enters the bacteria while the viral proteins do not and that this DNA can
be found in progeny virus particles.
1953: Rosalind Franklin and Maurice Wilkins use X-ray analyses to demonstrate
that DNA has a regularly repeating helical structure.
1953: James Watson and Francis Crick discover the molecular structure of DNA:
a double helix in which A always pairs with T, and C always with G.
1956: Arthur Kornberg discovers DNA polymerase.
1957: Francis Crick proposes the ”central dogma” (information in the DNA is
translated into proteins through RNA) and speculates that three bases in the
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DNA always specify one amino acid in a protein.
1958: Matthew Meselson and Franklin Stahl describe how DNA replicates (semi-
conservative replication).
1961 - 1966: Robert W. Holley, Har Gobind Khorana, Heinrich Matthaei, Mar-
shall W. Nirenberg, and colleagues crack the genetic code.
1968 - 1970: Werner Arber, Hamilton Smith, and Daniel Nathans use restric-
tion enzymes to cut DNA in specific places for the first time.
1972: Paul Berg uses restriction enzymes to create the first piece of recombinant
DNA.
1977: Frederick Sanger, Allan Maxam, and Walter Gilbert develop methods to
sequence DNA.
1982: The first drug (human insulin), based on recombinant DNA, appears on
the market.
1983: Kary Mullis invents PCR as a method for amplifying DNA in vitro.
1990: Sequencing of the human genome begins.
1995: First complete sequence of the genome of a free-living organism (the bac-
terium Haemophilus influenzae) is published.
1996: The complete genome sequence of the first eukaryotic organism - the yeast
S. cerevisiae - is published.
1998: Complete genome sequence of the first multi-cellular organism - the ne-
matode worm Caenorhabditis elegans - is published.
1999: Sequence of the first human chromosome (22) is published.
2000: The complete sequences of the genomes of the fruit fly Drosophila and the
first plant - Arabidopsis - are published.
2001: The complete sequence of the human genome is published.
2002: The complete genome sequence of the first mammalian model organism -
the mouse - is published.
2005: 454 pyrosequencing has appeared.
2008: Illumina DNA sequencing technology (sequencing by synthesis) has ap-
peared.
2009: SoLiD (sequencing by ligation) has appeared.
2011: PacBio DNA sequencing technology has appeared.
2013: Oxford Nanopore DNA sequencing technology has appeared. [39]
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